DAPGM's decision to buy back, incentive to Eplast, merger move in Ardyz: current news from BIST companies

Investing.com - You can check out our summary of current company news that we prepare according to the announcements made by companies listed on the Istanbul Stock Exchange in the continuation of our content.

Investing.com - The stock exchange is in Istanbul You can take a look at our summary of current company news, which we prepare based on the notifications made by the listed companies, in the continuation of our content.

Ayes Çelik signs contract for new factory construction in Aliaga

Ayes Çelik Mesır ve Çit Sanayi A.Ş. (AYES) has taken another important step within the scope of the factory investment it will implement in Aliaga Kimya Specialized and Mixed Organized Industrial Zone (OSB). The company entered into an agreement with Kibtaş Engineering and Construction Industry and Trade Ltd. Ltd., for the construction of a reinforced concrete factory building with a size of 8,251 square meters. The contract is worth a total of 91 million TL, excluding mechanical and electrical works.

The construction project in question will benefit from VAT exemption by being included in the scope of the investment incentive. The company reports that it will cover the cost of construction with its own resources. The work will start on August 26, 2025, and the project is expected to be completed within 180 days.

See AYES Fair Value

Dap Real Estate ends its repurchase program

DAP Real Estate Development A.Ş. (DAPGM) terminated the repurchases it initiated on December 18, 2024 within the framework of the Share Repurchase Program approved at the Extraordinary General Meeting of December 16, 2024. The program, which was terminated as of August 25, 2025, was reportedly closed due to the achievement of the set goals.

The company stated that the results obtained in the buyback process were adequate and fit for purpose, stating that no new decision has been made regarding the shares acquired under the program.

Egeplast receives investment incentive certificate for production increase

Egeplast Ege Plastik Ticaret ve Sanayi A.Ş. (EPLAS) has received an investment incentive certificate from the Ministry of Industry and Technology regarding the investment projects it plans to carry out aimed at increasing its production capacity. The document received on August 25 and registered as number 600726 will provide significant support in line with the company's growth targets.

The validity period of the incentive document will continue until August 8, 2028, and the total fixed investment amount is reported to be 196,207.183 TL. In addition to increasing capacity with the realization of the investment, it is also aimed at increasing the competitiveness of the company.

Fertilizer Factories declares that the allegations in the media do not reflect the truth

Gübre Fabrikaları T.A.Ş. (GUBRF) stated that recent media reports on issues such as strikes, supply and sale of real estate do not reflect the truth. In a statement, the company stressed that the allegations are misleading and inconsistent with the truth.

In the legal framework, it was stated that the strike process between the workers' and employers' unions proceeded correctly and transparently. In addition, the company announced that the aforementioned unfounded news has a negative impact on both the corporate image and stock exchange investors, stating that they reserve their legal rights.

MLP Sağlık takes over the license of the Private Medistanbul Hospital

MLP Sağlık Hizmetleri A.Ş. (MPARK) has completed the license transfer of Private Medistanbul Hospital, which operates in Istanbul. With this acquisition carried out on August 25, 2025, the name of the hospital was changed to Özel Medicalpark Tem Hastanesi.

The hospital, which has a total of 35,000 square meters of enclosed space and a capacity of 62 beds, is planned to increase its bed capacity to 150 with a new license. The company also stated that in the interest of the healthy progress of the process, the announcement was previously postponed within the framework of the relevant communication of the Capital Market Board, and that the notification was made after the reasons for the postponement had disappeared.

Ard Grup starts non-binding talks with Intron Bişim

Ard Grup Bişim Teknolojleri A.Ş. (ARDYZ)., in line with its growth goals in the software and technology field, decided to start merger talks by taking over Intron BiliŞim. These non-binding talks were announced as part of a strategy to open up to new markets and expand the product portfolio.

Together with areas such as artificial intelligence, cybersecurity, AR/VR, and data analytics that ARD Group specializes in, it is aimed to create a significant synergy by combining the system infrastructure and security solutions offered by Intron Informatics to public institutions and large-scale customers. Thus, it is expected that the company will have access to a wider network of markets in its domestic and overseas operations.

Measure applied to CUSAN, IHYAY and MERCN shares under VBTS

According to a statement made by Borsa İstanbul via the Public Disclosure Platform (KAP), a gross swap of CUSAN shares was implemented from August 26, 2025 until the end of the session on September 25, 2025, under the Volatility Based Measure System (VBTS). In this process, it is reported that previous measures, such as the ban on credit transactions, which is present in the relevant denominator, will also continue.

In addition, similar measures were taken in IHYAY and MERCN shares under the same system. Both stocks will be subject to a ban on short selling and credit trading from the beginning of the session on August 26, 2025 until the end of the session on September 25, 2025. These measures were put in place with the aim of protecting investors in the market and preventing excessive fluctuations.

Continue Reading at Investing.com Turkey

⚖️ Yasal Uyarı:Bu içerik yatırım tavsiyesi niteliği taşımaz. Yatırımlarınızla ilgili kararlarınızı kendi araştırmalarınız ve risk profilinize göre almanız önerilir.

Recall of DAPGM

İlginizi Çekebilir

Our Trusted Partners